Skip to main content
. 2019 Oct 22;14:182. doi: 10.1186/s13014-019-1387-9

Table 2.

Survival rate of NPC patients with N3 disease

Three years All Patients Chemoradiotherapy-non-MC Patients (n = 109) Chemoradiotherapy-MC Patients (n = 21) χ2 p value
OS 79.2% 76.3% 95.2% 2.999 0.046
DMFS 73.6% 70.3% 90.5% 4.111 0.043
LFFS 88.2% 84.9% 100% 2.851 0.091

Abbreviations: MC Maintenance chemotherapy, OS Overall survival, DMFS Distant metastasis-survival, LFFS Locoregional failure-free survival